Silvercrest Asset Management Group LLC Maxcyte, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $13.6 Billion
- Q1 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 1,074,631 shares of MXCT stock, worth $2.43 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,074,631
Previous 1,080,837
0.57%
Holding current value
$2.43 Million
Previous $4.5 Million
34.76%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$22.7 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$18.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.6 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.4 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $230M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...